News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. AMSBIO Introduces New CRISPR gRNA Lentivector Cloning Kits

AMSBIO Introduces New CRISPR gRNA Lentivector Cloning Kits14/07/2016Abingdon, 2016 – Anglo-American life science firm AMSBIO has introduced new CRISPR gRNA Lentivector Cloning Kits that provide scientists with a targeted and precise genomic gene editing methodology.Targeted and precise genomic gene editing technologies are today key tools for genomic correction, modification and gene therapy.  The recently discovered CRISPR/Cas gene editing technique offe


2. Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Ap

Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology02/08/2016Gosport, UK – Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide.This joint study on “Evaluating different concentrations of hydrogen peroxide in an automated room disinfection system.” has recently been published in the leading scientific journal Letters in Applied Microbiolo


3. Global Cooperation Feasibility Studies: Apply for Funding

Global Cooperation Feasibility Studies: Apply for Funding 05/08/2016UK businesses could win a share of £1.2 million to carry out short, international cooperation feasibility studies.UK businesses looking to create international business networks can apply for funding of up to £21,000. This funding is to enable commercial research and innovation partnerships. It will also help businesses explore ideas for future collaboration.Innovate UK is funding this competition. It is open to s


4. Summit Reports Positive Phase 1 Data and Outlines Route to Market Stra

Summit Reports Positive Phase 1 Data and Outlines Route to Market Strategy for DMD Candidate Ezutromid 09/08/2016Oxford, UK,  – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and Clostridium difficile infection, today reports Phase 1 clinical trial results that show a new formulation of ezutromid (referred to as ‘F6’) achieved a greater than six-fold increase in maxi


5. Cambridge Innovation Capital Raises £75 million Via Private Financing

Cambridge Innovation Capital Raises £75 million Via Private Financing19/07/2016Cambridge, UK – Cambridge Innovation Capital plc, a preferred investor for the University of Cambridge and a Cambridge-based investor in technology and healthcare companies, announces that it has raised £75m of new capital (the “Fundraising”).CIC was founded in 2013 as an initiative by the University of Cambridge to create a local entity that would be able to provide growth capital to promi



Page 14 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2019